Pain Relief Drug

Approx. Rs 800 / BoxGet Latest Price

Baricitinib tablets are a prescription medication used in the treatment of moderate to severe rheumatoid arthritis (RA) in adult patients who have not responded well to other disease-modifying antirheumatic drugs (DMARDs). Baricitinib belongs to a class of medications known as Janus kinase (JAK) inhibitors, which work by inhibiting specific enzymes involved in the inflammatory process. Here are some key points about Baricitinib tablets:

1. Treatment of Rheumatoid Arthritis: Baricitinib tablets are indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have had an inadequate response or intolerance to one or more DMARDs. Rheumatoid arthritis is a chronic autoimmune disease that causes inflammation, pain, stiffness, and joint damage.

2. Mode of Action: Baricitinib inhibits the activity of Janus kinases (JAKs), particularly JAK1 and JAK2, which are enzymes involved in the signaling pathways of pro-inflammatory cytokines such as interleukin-6 (IL-6) and interferon-gamma (IFN-γ). By blocking these pathways, Baricitinib helps reduce inflammation and slow the progression of joint damage in rheumatoid arthritis.

3. Dosage Forms: Baricitinib is available in tablet form for oral administration. Each tablet typically contains a specific dosage of Baricitinib, commonly ranging from 1 mg to 4 mg, although dosages may vary depending on the individual's disease severity and response to treatment.

4. Dosage and Administration: The recommended dosage of Baricitinib tablets for the treatment of rheumatoid arthritis is usually 2 mg once daily, taken orally with or without food. However, dosage adjustments may be necessary based on the patient's response to treatment and any concomitant medications being taken. It is important to follow the prescribed dosage regimen as directed by a healthcare professional.

5. Safety and Side Effects: While generally well-tolerated, Baricitinib tablets may cause side effects in some individuals. Common side effects may include upper respiratory tract infections, nausea, headache, and hypertension. Serious side effects such as increased risk of infections, thrombosis, liver enzyme elevations, and gastrointestinal perforations are possible and require monitoring by a healthcare provider.

6. Monitoring and Precautions: Before initiating treatment with Baricitinib, healthcare providers may perform baseline laboratory tests and assess the patient's medical history to identify any risk factors or contraindications. Regular monitoring of blood counts, liver function, and lipid levels may be necessary during treatment.

7. Contraindications: Baricitinib tablets are contraindicated in patients with a history of hypersensitivity to Baricitinib or any of its components. It should not be used in combination with other JAK inhibitors or biologic DMARDs.

Baricitinib tablets offer a targeted treatment option for adult patients with moderate to severe rheumatoid arthritis who have not responded adequately to other DMARDs. When used as directed and under the supervision of a healthcare professional, Baricitinib can help reduce inflammation, relieve symptoms, and improve the overall quality of life for individuals living with rheumatoid arthritis.

Additional Information: